CD4 and acute respiratory distress syndrome: Similar research has also demonstrated significantly reduced CD4+, CD8+, and B lymphocyte counts in ARDS patients, along with activation of Th1 and Th2, inflammatory response cell apoptosis, cytotoxicity, and endothelial dysfunction (70, 71).